The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Formulation Development Outsourcing-Global Market Insights and Sales Trends 2024
Synopsis
Formulation development is a major area of product/drug development that determines the patentability, lifecycle, and success of a pharmaceutical product. Most pharmaceutical companies outsource formulation services to minimize the time and investment involved in trials.
The global Formulation Development Outsourcing market size is expected to reach US$ 59300 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Formulation Development Outsourcing in various end use industries. The expanding demands from the Pharmaceutical and Biopharmaceutical Companies, Government and Academic Institutes and Others,, are propelling Formulation Development Outsourcing market. Pre-formulation Services, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Formulation Optimization segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Formulation Development Outsourcing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Formulation Development Outsourcing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Formulation Development Outsourcing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Formulation Development Outsourcing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Formulation Development Outsourcing covered in this report include Charles River Laboratories, Aizant Drug Research Solutions, Catalent, Labcorp, Syngene, Irisys, Intertek Group, Piramal Pharma Solutions and Qiotient Sciences, etc.
The global Formulation Development Outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Charles River Laboratories
Aizant Drug Research Solutions
Catalent
Labcorp
Syngene
Irisys
Intertek Group
Piramal Pharma Solutions
Qiotient Sciences
Patheon
Emergent BioSolutions
Lonza Group
Dr. Reddy's Laboratories
Global Formulation Development Outsourcing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Formulation Development Outsourcing market, Segment by Type:
Pre-formulation Services
Formulation Optimization
Global Formulation Development Outsourcing market, by Application
Pharmaceutical and Biopharmaceutical Companies
Government and Academic Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Formulation Development Outsourcing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Formulation development is a major area of product/drug development that determines the patentability, lifecycle, and success of a pharmaceutical product. Most pharmaceutical companies outsource formulation services to minimize the time and investment involved in trials.
The global Formulation Development Outsourcing market size is expected to reach US$ 59300 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Formulation Development Outsourcing in various end use industries. The expanding demands from the Pharmaceutical and Biopharmaceutical Companies, Government and Academic Institutes and Others,, are propelling Formulation Development Outsourcing market. Pre-formulation Services, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Formulation Optimization segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Formulation Development Outsourcing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Formulation Development Outsourcing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Formulation Development Outsourcing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Formulation Development Outsourcing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Formulation Development Outsourcing covered in this report include Charles River Laboratories, Aizant Drug Research Solutions, Catalent, Labcorp, Syngene, Irisys, Intertek Group, Piramal Pharma Solutions and Qiotient Sciences, etc.
The global Formulation Development Outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Charles River Laboratories
Aizant Drug Research Solutions
Catalent
Labcorp
Syngene
Irisys
Intertek Group
Piramal Pharma Solutions
Qiotient Sciences
Patheon
Emergent BioSolutions
Lonza Group
Dr. Reddy's Laboratories
Global Formulation Development Outsourcing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Formulation Development Outsourcing market, Segment by Type:
Pre-formulation Services
Formulation Optimization
Global Formulation Development Outsourcing market, by Application
Pharmaceutical and Biopharmaceutical Companies
Government and Academic Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Formulation Development Outsourcing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Formulation Development Outsourcing
1.1 Formulation Development Outsourcing Market Overview
1.1.1 Formulation Development Outsourcing Product Scope
1.1.2 Formulation Development Outsourcing Market Status and Outlook
1.2 Global Formulation Development Outsourcing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Formulation Development Outsourcing Market Size by Region (2018-2029)
1.4 Global Formulation Development Outsourcing Historic Market Size by Region (2018-2023)
1.5 Global Formulation Development Outsourcing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Formulation Development Outsourcing Market Size (2018-2029)
1.6.1 North America Formulation Development Outsourcing Market Size (2018-2029)
1.6.2 Europe Formulation Development Outsourcing Market Size (2018-2029)
1.6.3 Asia-Pacific Formulation Development Outsourcing Market Size (2018-2029)
1.6.4 Latin America Formulation Development Outsourcing Market Size (2018-2029)
1.6.5 Middle East & Africa Formulation Development Outsourcing Market Size (2018-2029)
2 Formulation Development Outsourcing Market by Type
2.1 Introduction
2.1.1 Pre-formulation Services
2.1.2 Formulation Optimization
2.2 Global Formulation Development Outsourcing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Formulation Development Outsourcing Historic Market Size by Type (2018-2023)
2.2.2 Global Formulation Development Outsourcing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Formulation Development Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Formulation Development Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Formulation Development Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Formulation Development Outsourcing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Formulation Development Outsourcing Revenue Breakdown by Type (2018-2029)
3 Formulation Development Outsourcing Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical and Biopharmaceutical Companies
3.1.2 Government and Academic Institutes
3.1.3 Others
3.2 Global Formulation Development Outsourcing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Formulation Development Outsourcing Historic Market Size by Application (2018-2023)
3.2.2 Global Formulation Development Outsourcing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Formulation Development Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Formulation Development Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Formulation Development Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Formulation Development Outsourcing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Formulation Development Outsourcing Revenue Breakdown by Application (2018-2029)
4 Formulation Development Outsourcing Competition Analysis by Players
4.1 Global Formulation Development Outsourcing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Formulation Development Outsourcing as of 2022)
4.3 Date of Key Players Enter into Formulation Development Outsourcing Market
4.4 Global Top Players Formulation Development Outsourcing Headquarters and Area Served
4.5 Key Players Formulation Development Outsourcing Product Solution and Service
4.6 Competitive Status
4.6.1 Formulation Development Outsourcing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Charles River Laboratories
5.1.1 Charles River Laboratories Profile
5.1.2 Charles River Laboratories Main Business
5.1.3 Charles River Laboratories Formulation Development Outsourcing Products, Services and Solutions
5.1.4 Charles River Laboratories Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.1.5 Charles River Laboratories Recent Developments
5.2 Aizant Drug Research Solutions
5.2.1 Aizant Drug Research Solutions Profile
5.2.2 Aizant Drug Research Solutions Main Business
5.2.3 Aizant Drug Research Solutions Formulation Development Outsourcing Products, Services and Solutions
5.2.4 Aizant Drug Research Solutions Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.2.5 Aizant Drug Research Solutions Recent Developments
5.3 Catalent
5.3.1 Catalent Profile
5.3.2 Catalent Main Business
5.3.3 Catalent Formulation Development Outsourcing Products, Services and Solutions
5.3.4 Catalent Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.3.5 Labcorp Recent Developments
5.4 Labcorp
5.4.1 Labcorp Profile
5.4.2 Labcorp Main Business
5.4.3 Labcorp Formulation Development Outsourcing Products, Services and Solutions
5.4.4 Labcorp Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.4.5 Labcorp Recent Developments
5.5 Syngene
5.5.1 Syngene Profile
5.5.2 Syngene Main Business
5.5.3 Syngene Formulation Development Outsourcing Products, Services and Solutions
5.5.4 Syngene Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.5.5 Syngene Recent Developments
5.6 Irisys
5.6.1 Irisys Profile
5.6.2 Irisys Main Business
5.6.3 Irisys Formulation Development Outsourcing Products, Services and Solutions
5.6.4 Irisys Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.6.5 Irisys Recent Developments
5.7 Intertek Group
5.7.1 Intertek Group Profile
5.7.2 Intertek Group Main Business
5.7.3 Intertek Group Formulation Development Outsourcing Products, Services and Solutions
5.7.4 Intertek Group Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.7.5 Intertek Group Recent Developments
5.8 Piramal Pharma Solutions
5.8.1 Piramal Pharma Solutions Profile
5.8.2 Piramal Pharma Solutions Main Business
5.8.3 Piramal Pharma Solutions Formulation Development Outsourcing Products, Services and Solutions
5.8.4 Piramal Pharma Solutions Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.8.5 Piramal Pharma Solutions Recent Developments
5.9 Qiotient Sciences
5.9.1 Qiotient Sciences Profile
5.9.2 Qiotient Sciences Main Business
5.9.3 Qiotient Sciences Formulation Development Outsourcing Products, Services and Solutions
5.9.4 Qiotient Sciences Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.9.5 Qiotient Sciences Recent Developments
5.10 Patheon
5.10.1 Patheon Profile
5.10.2 Patheon Main Business
5.10.3 Patheon Formulation Development Outsourcing Products, Services and Solutions
5.10.4 Patheon Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.10.5 Patheon Recent Developments
5.11 Emergent BioSolutions
5.11.1 Emergent BioSolutions Profile
5.11.2 Emergent BioSolutions Main Business
5.11.3 Emergent BioSolutions Formulation Development Outsourcing Products, Services and Solutions
5.11.4 Emergent BioSolutions Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.11.5 Emergent BioSolutions Recent Developments
5.12 Lonza Group
5.12.1 Lonza Group Profile
5.12.2 Lonza Group Main Business
5.12.3 Lonza Group Formulation Development Outsourcing Products, Services and Solutions
5.12.4 Lonza Group Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.12.5 Lonza Group Recent Developments
5.13 Dr. Reddy's Laboratories
5.13.1 Dr. Reddy's Laboratories Profile
5.13.2 Dr. Reddy's Laboratories Main Business
5.13.3 Dr. Reddy's Laboratories Formulation Development Outsourcing Products, Services and Solutions
5.13.4 Dr. Reddy's Laboratories Formulation Development Outsourcing Revenue (US$ Million) & (2018-2023)
5.13.5 Dr. Reddy's Laboratories Recent Developments
6 North America
6.1 North America Formulation Development Outsourcing Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Formulation Development Outsourcing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Formulation Development Outsourcing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Formulation Development Outsourcing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Formulation Development Outsourcing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Formulation Development Outsourcing Market Dynamics
11.1 Formulation Development Outsourcing Industry Trends
11.2 Formulation Development Outsourcing Market Drivers
11.3 Formulation Development Outsourcing Market Challenges
11.4 Formulation Development Outsourcing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
